Specific Metabolic Pathways Regulate Inflammation in Metabolic Dysfunction-Associated Steatotic Liver Disease
Files
Document Type
Poster
Publication Date
10-1-2025
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is becoming increasingly prevalent worldwide. Yet, the knowledge of disease mechanisms and available therapies are highly limited. To better understand the disease and provide potential treatments, our lab utilized various mice and in vitro models in order to determine how specific metabolic pathways impact disease progression. Combined, our findings and prior work in the lab provide novel insights for potential predictive, preventive, and therapeutic avenues.
Department
Department of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Project Mentor
Keisuke Sawada and Senad Divanovic
Recommended Citation
Williams Fonner, Ethan S.O. and al., et, "Specific Metabolic Pathways Regulate Inflammation in Metabolic Dysfunction-Associated Steatotic Liver Disease" (2025). Annual Student Research Poster Session. 208.
https://scholarship.depauw.edu/srfposters/208
Funding and Acknowledgements
National Institute of Health, American Diabetes Association, American Heart Association, and CCHMC Albert B. Sabin Fellowship